A New Cell Counting Method to Evaluate Anti-tumor Compound Activity |
Wang, Xue-Jian
(School of Pharmacy and Biology Science, Weifang Medical University)
Zhang, Xiu-Rong (School of Pharmacy and Biology Science, Weifang Medical University) Zhang, Lei (School of Medicine, Qingdao University) Li, Qing-Hua (School of Public Health, Weifang Medical University) Wang, Lin (School of Pharmacy and Biology Science, Weifang Medical University) Shi, Li-Hong (School of Pharmacy and Biology Science, Weifang Medical University) Fang, Chun-Yan (School of Pharmacy and Biology Science, Weifang Medical University) |
1 | Cheng DD, Yang QC, Zhang ZC, Yang CX, Liu YW (2012). Antitumor activity of histone deacetylase inhibitor trichostatin A in osteosarcoma cells. Asian Pac J Cancer Prev, 13, 1395-99. 과학기술학회마을 DOI ScienceOn |
2 | Chueh AC, Togel L, Mariadason J, Tse JW (2014). Mechanisms of HDAC inhibitor-regulated gene expression in cancer cells. Antioxid Redox Signal, [Epub ahead of print]. |
3 | Dhar SS, Alam H, Li N, et al (2014). Transcriptional Repression of Histone Deacetylase 3 by the Histone Demethylase KDM2A Is Coupled to Tumorigenicity of Lung Cancer Cells. J Biol Chem, 289, 7483-96. DOI ScienceOn |
4 | Feng W, Zhang B, Cai D, Zou X (2014). Therapeutic potential of histone deacetylase inhibitors in pancreatic cancer. Cancer Lett, 347, 183-90. DOI ScienceOn |
5 | Okudela K, Mitsui H, Suzuki T, et al (2013). Expression of HDAC9 in lung cancer - potential role in lung carcinogenesis. Int J Clin Exp Pathol, 7, 213-20. |
6 | Richon VM, Emiliani S, Verdin E, et al (1998). A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A, 95, 3003-7. DOI ScienceOn |
7 | Sriraksa R, Limpaiboon T (2013). Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings. Asian Pac J Cancer Prev, 14, 2503-8. 과학기술학회마을 DOI ScienceOn |
8 | Wang SH, Li N, Wei Y, Li QR, Yu ZP (2014). beta-catenin deacetylation is essential for WNTinduced proliferation of breast cancer cells. Mol Med Rep, 9, 973-78. |
9 | Tesei A, Ulivi P, Fabbri F, et al (2005). In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines. J Transl Med, 3, 7. DOI ScienceOn |
10 | Thiagalingam S, Cheng KH, Lee HJ, et al (2003). Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci, 983, 84-100. DOI ScienceOn |
11 | Ueda H, Nakajima H, Hori Y, et al (1994). FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiot, 47, 301-10. DOI |
12 | Zhang QC, Jiang SJ, Zhang S, Ma XB (2012). Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. Asian Pac J Cancer Prev, 13, 3471-6. 과학기술학회마을 DOI ScienceOn |
13 | Zhang W, Ji W, Liu X, Ouyang G, Xiao W (2014). ELL inhibits E2F1 transcriptional activity by enhancing E2F1 deacetylation via recruitment of histone deacetylase 1. Mol Cell Biol, 34, 765-75. DOI ScienceOn |
14 | Zhang Y, Feng J, Liu C, et al (2010). Design, synthesis and preliminary activity assay of 1, 2, 3, 4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel histone deacetylases (HDACs) inhibitors. Bioorg Med Chem, 18, 1761-72. DOI ScienceOn |
![]() |